# A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia.

> **NCT00364832** · PHASE2 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 137 (actual)

## Conditions studied

- Anemia

## Interventions

- **DRUG:** methoxy polyethylene glycol-epoetin beta [Mircera]

## Key facts

- **NCT ID:** NCT00364832
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-10
- **Primary completion:** 2005-07
- **Final completion:** 2005-07
- **Target enrollment:** 137 (ACTUAL)
- **Last updated:** 2016-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00364832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00364832, "A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00364832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*